Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Average Rating of “Moderate Buy” by Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average rating of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $10.50.

A number of analysts have recently commented on the company. Barclays dropped their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a research report on Friday, March 20th. BMO Capital Markets decreased their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd.

Aveanna Healthcare Price Performance

AVAH stock opened at $7.33 on Friday. Aveanna Healthcare has a 1 year low of $3.73 and a 1 year high of $10.32. The firm has a market capitalization of $1.60 billion, a PE ratio of 6.21, a price-to-earnings-growth ratio of 0.91 and a beta of 1.93. The business has a 50 day simple moving average of $6.75 and a 200-day simple moving average of $7.85. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. The business had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s revenue was up 15.9% on a year-over-year basis. Equities research analysts anticipate that Aveanna Healthcare will post 0.56 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 125,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. This trade represents a 37.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 5.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AVAH. Caitong International Asset Management Co. Ltd grew its position in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter worth $43,000. Summit Securities Group LLC acquired a new stake in Aveanna Healthcare in the 1st quarter worth $53,000. Oxford Asset Management LLP acquired a new stake in Aveanna Healthcare in the 2nd quarter worth $64,000. Finally, Bayesian Capital Management LP acquired a new stake in Aveanna Healthcare in the 2nd quarter worth $85,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.